Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Please note that all translations are automatically generated. Click here for the English version.
DOI :
10.3791/59473-v
June 26th, 2019
Chapters
0:04
Title
0:38
Initial Afatinib PC-9 Cell Exposure Determination by 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) Assay
1:46
Continuous Afatinib Exposure
3:01
PC-9 Cell Growth Curve Determination
3:46
Epidermal Growth Factor Receptor (EGFR) Genomic DNA Alteration Evaluation
4:53
Epidermal Growth Factor Receptor (EGFR) Protein Alteration Evaluation
7:39
Results: Afatinib-resistant Cell Characterization
8:59
Conclusion
폐 선암종 PC-9 세포로부터 아파티닙 내성 세포주를 확립하는 방법이 개발되었고, 내성 세포가 특징지어졌다. 내성 세포는 비소세포 폐암 환자에게 적용되는 표피 성장인자 수용체 티로신 키나아제 억제제 내성 메커니즘을 조사하는데 사용될 수 있다.
Tags
-- Views
Related Videos
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit
Librarians
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
ABOUT JoVE
Leadership
Copyright © 2024 MyJoVE Corporation. All rights reserved